The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

Technology can help better control blood sugar and simplify managing type 2 diabetes. This article discusses some of the best ways to use technology for diabetes. Continuous glucose monitoring ...

The trade show floor offers a firsthand look at how market trends shape current design and manufacturing innovations. Attendees at MD&M West 2025 could navigate emerging trendlines, shifting industry ...

which are used to dispense insulin and other medications. Users of the devices in the UK will shortly be able to recycle empty pens at around 2,500 Boots, Lloyds, Rowlands, and various independent ...

Continuous glucose monitoring (CGM) is wearable technology used to monitor glucose levels at all times. A sensor is placed beneath the arm's or belly's skin and reads interstitial glucose, which is ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...